Research Management - Sep 29
Sorbonne University builds on its real estate assets and renovates its research facilities
Sorbonne University builds on its real estate assets and renovates its research facilities
news
« BACK
Health - Pharmacology - 28.06.2022
Health - Pharmacology - 04.05.2022 
Influenza: A New Avenue for Developing Innovative Treatments
Seasonal influenza is a major public health issue because it continues to remain associated with considerable mortality, particularly among people who are elderly, immunocompromised, or both. It also has a significant socioeconomic cost. With vaccination and current treatments still being of limited efficacy, research teams are trying to develop new therapeutic approaches.
Health - Pharmacology - 20.04.2022 
Infertility: New Avenues to Understand the Harmful Effects of Chemotherapy
Infertility is a public health problem affecting millions of couples in France. Among the possible causes, chemotherapy has been singled out as having particularly harmful effects on the fertility of both women and men. In order to better prevent and restore fertility in cancer survivors, understanding the mechanisms behind these negative effects is a priority.
Health - Pharmacology - 12.04.2022 
HIV: The Antibodies of ’Post-treatment Controllers’
A very small percentage of people with HIV-1, known as "post-treatment controllers” (PTCs), are able to control their infection after interrupting all antiretroviral therapy. Understanding the fundamental mechanisms that govern their immune response is essential in order to develop HIV-1 vaccines, novel therapeutic strategies to achieve remission, or both.
Life Sciences - Pharmacology - 11.04.2022
Pharmacology - Health - 24.03.2022
Health - Pharmacology - 21.03.2022 
COVID-19: ’Reactive’ Vaccination, Effective in Case of High Viral Circulation?
Although the majority of its population is fully vaccinated, the virus continues to actively circulate in France. As health restrictions are being lifted, fears of a resurgence of the epidemic and of the emergence of new more contagious variants are leading scientists to consider new strategies to continue to promote vaccination among populations that remain hesitant.
Health - Pharmacology - 14.03.2022 
MICA: A New Immune Response Gene That Predicts Kidney Transplant Failure
Although a kidney transplant is the only curative treatment for end-stage kidney disease, the risk of the patient's body rejecting the graft means that success is not guaranteed. To reduce this risk, physicians are now able to look at a certain number of genetic and immunological parameters in order to evaluate the histocompatibility between donor and recipient - i.e. how compatible their organs and tissues are.
Health - Pharmacology - 28.02.2022 
Covid-19 - Towards a vaccination strategy adapted to immunosuppressed patients
Publication of the CIRI in the journal Science Translational Medicine on February 1 st , 2022. Claude Bernard Lyon 1 University focus on February 24, 2022. Transplant recipients, who receive therapeutic immunosuppression to prevent graft rejection, are characterized by high coronavirus disease 2019 (COVID-19)-related mortality and defective response to vaccines.
Health - Pharmacology - 24.02.2022 
Discovery of an innate immunological memory in the intestine
The innate immune system plays a crucial role in regulating host-microbe interactions, and especially in providing protection against pathogens that invade the mucosa. Using an intestinal infection model, scientists from the Institut Pasteur and Inserm discovered that innate effector cells - group 3 innate lymphoid cells - act not only during the early stages of infection but can also be trained to develop an innate form of immunological memory that can protect the host during reinfection.
Health - Pharmacology - 24.02.2022 
Better Understanding the Role of a White Blood Cell Type in SARS-CoV-2 Immune Response
Although the response of various immune cells to SARS-CoV-2 infection has been relatively well studied, that of basophils (a category of white blood cells) had not been characterized yet - mainly because of their rarity in that they represent around 0.5% of the body's white blood cells. In a new study, researchers from Inserm, Sorbonne Université, Université de Paris, CNRS, Institut Pasteur and Efrei describe how basophils respond to SARS-CoV-2 infection.
Health - Pharmacology - 17.02.2022 
Defeating leukaemia cells by depriving them of energy
Selective activation of the AMPK enzyme would lead to the death of leukaemia cells (in purple in this image). Jérôme Tamburini / UNIGE High resolution pictures A Swiss-French team that includes scientists has discovered how to trigger apoptosis in leukaemia cells by disrupting their energy maintenance mechanism.
Health - Pharmacology - 11.02.2022 
A Novel Immunotherapy Approach Redirects Epstein-Barr Antibodies toward Disease-Causing Cells
Monoclonal antibody therapy can be very effective in treating numerous illnesses, such as cancers, chronic inflammatory conditions, and infectious diseases. However, it is costly and uses molecules that are complicated to produce. Therefore, it is essential to identify new therapeutic alternatives so that as many patients as possible get the treatments they need.
Health - Pharmacology - 03.02.2022 
Cancer Treatment: Identification of the Blood Vessels That Allow Killer Lymphocytes to Access and Destroy Tumors
Microscopic visualization of lymphocytes ( in green ) infiltrating a tumor HEV ( in red ) during combination anti-PD-1 plus anti-CTLA-4 immunotherapy. The white arrow indicates a lymphocyte that is leaving the bloodstream and entering the tumor ( Immunotherapy, a therapeutic strategy aimed at increasing the activity of the immune system in order to recognize and destroy cancer cells, has revolutionized cancer treatment over the past decade.
Health - Pharmacology - 01.02.2022 
COVID-19: A ’Programmed Cell Death’ Phenomenon in Hospitalized Patients
SARS-CoV-2 coronavirus responsible for COVID-19 disease attached to human respiratory epithelial cells. ©M.Rosa-Calatraval/O.Terrier/A.Pizzorno/E.Errazuriz-Cerda Almost 60% of patients hospitalized for COVID-19 have lymphopenia - a lower than normal number of lymphocytes in the blood circulation.
Health - Pharmacology - 26.01.2022 
Improvement in the Health of Two Infants with Severe Disharmonious Overgrowth Syndromes
Disharmonious overgrowth syndromes are rare genetic diseases associated with a PIK3CA gene mutation. Since 2016, a team of researchers from Inserm, Paris Public Hospitals Group (AP-HP), Université de Paris, the Disharmonious Overgrowth and Vascular Abnormalities Unit of Institut Necker-Enfants Malades and the clinical departments of Hospices Civils of Lyon has demonstrated the therapeutic efficacy of alpelisib, a molecule used to fight certain cancers, in treating a group of children and adults with severe forms of these diseases.
Pharmacology - 28.10.2021
Health - Pharmacology - 21.10.2021 
New, promising opportunities for treating skin fibrosis
Skin fibrosis impairs skin tissue function, and has a strong aesthetic impact. French researchers have now shown that applying an electric field to the skin could cure skin fibrosis by reducing overly high collagen levels. Collagen, the main component of the skin's extracellular matrix, can cause a pathological condition if it is in excess.
Health - Pharmacology - 20.10.2021 
A new therapeutic target to combat addiction?
Drug addiction is a psychiatric disorder for which no pharmacological treatment with long-term efficacy currently exists. All addictive substances share the property of raising concentrations of the neurotransmitter dopamine within brain regions forming the neural reward circuit. This increase in dopamine levels results in long-lasting alteration of signal transmission that is dependent on another neurotransmitter, glutamate, which causes addictive behaviours.
Health - Pharmacology - 01.12.2020 
Deciphering the energetic code of cells for better anticancer therapies
A procedure that may help personalise anticancer therapies has just been developed by the CNRS, INSERM, and Aix-Marseille University scientists at the Centre d'Immunologie de Marseille-Luminy, in association with colleagues from the University of California San Francisco and the Marseille Public University Hospital System (AP-HM), with support from Canceropôle Provence-Alpes-Côte d'Azur.
Pharmacology
Results 1 - 20 of 27.
Highly Effective Memory B Cells Localized in the Lungs
How can we increase the efficacy of vaccines used to protect against viral respiratory diseases such as influenza and COVID-19? Scientists from Inserm, CNRS and Aix-Marseille Université at the Center of Immunology Marseille-Luminy are opening up new prospects in the field, with the triggering of memory B cells directly in the lungs looking to be a promising avenue.
How can we increase the efficacy of vaccines used to protect against viral respiratory diseases such as influenza and COVID-19? Scientists from Inserm, CNRS and Aix-Marseille Université at the Center of Immunology Marseille-Luminy are opening up new prospects in the field, with the triggering of memory B cells directly in the lungs looking to be a promising avenue.
Seasonal influenza is a major public health issue because it continues to remain associated with considerable mortality, particularly among people who are elderly, immunocompromised, or both. It also has a significant socioeconomic cost. With vaccination and current treatments still being of limited efficacy, research teams are trying to develop new therapeutic approaches.
Infertility is a public health problem affecting millions of couples in France. Among the possible causes, chemotherapy has been singled out as having particularly harmful effects on the fertility of both women and men. In order to better prevent and restore fertility in cancer survivors, understanding the mechanisms behind these negative effects is a priority.
A very small percentage of people with HIV-1, known as "post-treatment controllers” (PTCs), are able to control their infection after interrupting all antiretroviral therapy. Understanding the fundamental mechanisms that govern their immune response is essential in order to develop HIV-1 vaccines, novel therapeutic strategies to achieve remission, or both.
Epigenetic treatments: New allies for chemotherapies?
If genetics is interested in gene sequencing, epigenetics studies how genes are going to be used, or not used, by a cell. The epigenome of a cell represents the set of chemical modifications of the DNA or associated proteins that will determine the expression of the genes and thus the cell's identity.
If genetics is interested in gene sequencing, epigenetics studies how genes are going to be used, or not used, by a cell. The epigenome of a cell represents the set of chemical modifications of the DNA or associated proteins that will determine the expression of the genes and thus the cell's identity.
Increased Ischemic Stroke Risk Associated with Certain Medications for Nausea and Vomiting
Every year in France, 140,000 people have a stroke 1 . Around 80% are ischemic strokes or cerebral infarctions, which occur when a brain artery is obstructed by a blood clot. Studies have shown that the risk of ischemic stroke is increased by the use of antipsychotics: medications with antidopaminergic 2 properties that are commonly prescribed in psychiatry.
Every year in France, 140,000 people have a stroke 1 . Around 80% are ischemic strokes or cerebral infarctions, which occur when a brain artery is obstructed by a blood clot. Studies have shown that the risk of ischemic stroke is increased by the use of antipsychotics: medications with antidopaminergic 2 properties that are commonly prescribed in psychiatry.
Although the majority of its population is fully vaccinated, the virus continues to actively circulate in France. As health restrictions are being lifted, fears of a resurgence of the epidemic and of the emergence of new more contagious variants are leading scientists to consider new strategies to continue to promote vaccination among populations that remain hesitant.
Although a kidney transplant is the only curative treatment for end-stage kidney disease, the risk of the patient's body rejecting the graft means that success is not guaranteed. To reduce this risk, physicians are now able to look at a certain number of genetic and immunological parameters in order to evaluate the histocompatibility between donor and recipient - i.e. how compatible their organs and tissues are.
Publication of the CIRI in the journal Science Translational Medicine on February 1 st , 2022. Claude Bernard Lyon 1 University focus on February 24, 2022. Transplant recipients, who receive therapeutic immunosuppression to prevent graft rejection, are characterized by high coronavirus disease 2019 (COVID-19)-related mortality and defective response to vaccines.
The innate immune system plays a crucial role in regulating host-microbe interactions, and especially in providing protection against pathogens that invade the mucosa. Using an intestinal infection model, scientists from the Institut Pasteur and Inserm discovered that innate effector cells - group 3 innate lymphoid cells - act not only during the early stages of infection but can also be trained to develop an innate form of immunological memory that can protect the host during reinfection.
Although the response of various immune cells to SARS-CoV-2 infection has been relatively well studied, that of basophils (a category of white blood cells) had not been characterized yet - mainly because of their rarity in that they represent around 0.5% of the body's white blood cells. In a new study, researchers from Inserm, Sorbonne Université, Université de Paris, CNRS, Institut Pasteur and Efrei describe how basophils respond to SARS-CoV-2 infection.
Selective activation of the AMPK enzyme would lead to the death of leukaemia cells (in purple in this image). Jérôme Tamburini / UNIGE High resolution pictures A Swiss-French team that includes scientists has discovered how to trigger apoptosis in leukaemia cells by disrupting their energy maintenance mechanism.
Monoclonal antibody therapy can be very effective in treating numerous illnesses, such as cancers, chronic inflammatory conditions, and infectious diseases. However, it is costly and uses molecules that are complicated to produce. Therefore, it is essential to identify new therapeutic alternatives so that as many patients as possible get the treatments they need.
Microscopic visualization of lymphocytes ( in green ) infiltrating a tumor HEV ( in red ) during combination anti-PD-1 plus anti-CTLA-4 immunotherapy. The white arrow indicates a lymphocyte that is leaving the bloodstream and entering the tumor ( Immunotherapy, a therapeutic strategy aimed at increasing the activity of the immune system in order to recognize and destroy cancer cells, has revolutionized cancer treatment over the past decade.
SARS-CoV-2 coronavirus responsible for COVID-19 disease attached to human respiratory epithelial cells. ©M.Rosa-Calatraval/O.Terrier/A.Pizzorno/E.Errazuriz-Cerda Almost 60% of patients hospitalized for COVID-19 have lymphopenia - a lower than normal number of lymphocytes in the blood circulation.
Disharmonious overgrowth syndromes are rare genetic diseases associated with a PIK3CA gene mutation. Since 2016, a team of researchers from Inserm, Paris Public Hospitals Group (AP-HP), Université de Paris, the Disharmonious Overgrowth and Vascular Abnormalities Unit of Institut Necker-Enfants Malades and the clinical departments of Hospices Civils of Lyon has demonstrated the therapeutic efficacy of alpelisib, a molecule used to fight certain cancers, in treating a group of children and adults with severe forms of these diseases.
Chatbot for addressing COVID-19 vaccine hesitancy
A considerable fraction of the population is reluctant to get vaccinated against COVID-19. French scientists have designed a chatbot that offers personalised responses to questions posed by the curious or hesitant-and have demonstrated its effectiveness. What if a few minutes of interaction with a chatbot could effectively address vaccine concerns? In an article published in the Journal of Experimental Psychology: Applied (28 October 2021), researchers from the CNRS, INSERM, and ENS-PSL show that such an interface is indeed capable of swaying the vaccine-hesitant.
A considerable fraction of the population is reluctant to get vaccinated against COVID-19. French scientists have designed a chatbot that offers personalised responses to questions posed by the curious or hesitant-and have demonstrated its effectiveness. What if a few minutes of interaction with a chatbot could effectively address vaccine concerns? In an article published in the Journal of Experimental Psychology: Applied (28 October 2021), researchers from the CNRS, INSERM, and ENS-PSL show that such an interface is indeed capable of swaying the vaccine-hesitant.
Skin fibrosis impairs skin tissue function, and has a strong aesthetic impact. French researchers have now shown that applying an electric field to the skin could cure skin fibrosis by reducing overly high collagen levels. Collagen, the main component of the skin's extracellular matrix, can cause a pathological condition if it is in excess.
Drug addiction is a psychiatric disorder for which no pharmacological treatment with long-term efficacy currently exists. All addictive substances share the property of raising concentrations of the neurotransmitter dopamine within brain regions forming the neural reward circuit. This increase in dopamine levels results in long-lasting alteration of signal transmission that is dependent on another neurotransmitter, glutamate, which causes addictive behaviours.
A procedure that may help personalise anticancer therapies has just been developed by the CNRS, INSERM, and Aix-Marseille University scientists at the Centre d'Immunologie de Marseille-Luminy, in association with colleagues from the University of California San Francisco and the Marseille Public University Hospital System (AP-HM), with support from Canceropôle Provence-Alpes-Côte d'Azur.
Research Management - Sep 29
Sorbonne University builds on its real estate assets and renovates its research facilities
Sorbonne University builds on its real estate assets and renovates its research facilities